NCT03725059 · Interventional trial
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Overall registry status Active not recruiting
Phase 3
Conditions Breast Cancer
Delaware Valley sites
- Cancer Treatment Centers of America-Eastern Regional Medical Center ( Site 0076) · Philadelphia, PA · Philadelphia County
- Fox Chase Cancer Center ( Site 0078) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory